Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 14, 2018 - Issue 5
Submit an article Journal homepage
6,279
Views
8
CrossRef citations to date
0
Altmetric
Review

Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development

A. W. DretlerDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USAView further author information
,
N. G. RouphaelDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USAView further author information
&
D. S. StephensDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USACorrespondence[email protected]
View further author information
Pages 1146-1160 | Received 07 Dec 2017, Accepted 09 Mar 2018, Published online: 09 May 2018

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (8)

Gary S. Marshall, Stephen I. Pelton, Corwin A. Robertson & Philipp Oster. (2022) Immunogenicity and safety of MenACWY-TT, a quadrivalent meningococcal tetanus toxoid conjugate vaccine recently licensed in the United States for individuals ≥2 years of age. Human Vaccines & Immunotherapeutics 18:6.
Read now
Franco M. Piazza, Miia Virta, Marita Paassilta, Benita Ukkonen, Anitta Ahonen, Alejandra Esteves-Jaramillo, Aino Forsten, Ilkka Seppa, Jian Ding, David Neveu, Emilia Jordanov & Mandeep S. Dhingra. (2022) Immunogenicity and safety of an investigational quadrivalent meningococcal conjugate vaccine administered as a booster dose in children vaccinated against meningococcal disease 3 years earlier as toddlers: A Phase III, open-label, multi-center study. Human Vaccines & Immunotherapeutics 18:1, pages 1-10.
Read now
Federico Martinón-Torres, Isabelle Bertrand-Gerentes & Philipp Oster. (2021) A novel vaccine to prevent meningococcal disease beyond the first year of life: an early review of MenACYW-TT. Expert Review of Vaccines 20:9, pages 1123-1146.
Read now
Yumi Matsumura. (2020) Risk Analysis of Eculizumab-Related Meningococcal Disease in Japan Using the Japanese Adverse Drug Event Report Database. Drug, Healthcare and Patient Safety 12, pages 207-215.
Read now
Weichang Luo, Peter D. Arkwright & Ray Borrow. (2020) Antibody persistence following meningococcal ACWY conjugate vaccine licensed in the European Union by age group and vaccine. Expert Review of Vaccines 19:8, pages 745-754.
Read now
Federico Martinón-Torres, Lidia Serra & Marco Aurelio P. Safadi. (2020) Protecting the most vulnerable age group: a review of MenACWY-TT immunogenicity and safety in infants. Expert Review of Vaccines 19:4, pages 313-325.
Read now
Meltem Polat, Selçuk Yüksel & Nuriye Ünal Şahin. (2018) Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab. Human Vaccines & Immunotherapeutics 14:11, pages 2802-2802.
Read now
Aslinur Ozkaya-Parlakay, Saliha Kanik-Yuksek, Belgin Gulhan, Hasan Tezer, Filiz Altay & Nuriye Unal-Sahin. (2018) A refugee patient with meningococcal meningitis type B. Human Vaccines & Immunotherapeutics 14:9, pages 2329-2329.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.